New insider activity at Eli Lilly & Co ( (LLY) ) has taken place on September 19, 2025.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Lilly Endowment Inc, a significant shareholder of Eli Lilly & Co, has recently sold 106,626 shares of the company’s stock. This transaction amounts to a substantial $81,531,452.
Spark’s Take on LLY Stock
According to Spark, TipRanks’ AI Analyst, LLY is a Outperform.
Eli Lilly & Co’s overall stock score reflects strong financial performance and positive earnings call highlights, including significant revenue and earnings growth. However, high valuation and leverage, along with moderate technical indicators, temper the overall outlook. Strategic investments and product successes provide a cautiously optimistic future, despite some market challenges.
To see Spark’s full report on LLY stock, click here.
More about Eli Lilly & Co
YTD Price Performance: -0.58%
Average Trading Volume: 4,419,075
Technical Sentiment Signal: Buy
Current Market Cap: $719.4B